Trump ad­min­is­tra­tion dou­bles down on slash­ing the bud­get at NIH, FDA — with a user fee hike for bio­phar­ma

Pres­i­dent Don­ald Trump is stick­ing with a con­tro­ver­sial plan to try and carve bil­lions out of the bud­gets for the NIH and the FDA, look­ing to slash re­search spend­ing and force bio­phar­ma com­pa­nies to cough up more cash for drug re­views.

But his pro­pos­als are al­ready deep in hot wa­ter — and that’s be­fore you start count­ing De­mo­c­ra­t­ic votes. A num­ber of Re­pub­li­can law­mak­ers have reg­is­tered their op­po­si­tion to these kinds of cuts to the NIH and FDA, in­clud­ing some of the par­ty’s most pow­er­ful fig­ures.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER